https://acuity.news/regulation/naloxone-price-drop-federal-harm-reduction-funding-cuts-2026/Acuity Newsen2026-08-06T11:39:00-06:00Naloxone Has Never Been Cheaper, and the Money to Distribute It Is Disappearing. A Life-Saving Drug Falls to Nineteen Dollars Just as Federal Harm Reduction Funding Retreats. https://acuity.news/regulation/kansas-medicaid-aba-rates-2026-kmap-fee-schedule/Acuity Newsen2026-08-06T05:35:59-06:00Kansas Medicaid ABA Rates Have Not Moved Since 2019 on Every Code but One. The July 2026 KMAP Fee Schedule Reissues Them Unchanged, and the Autism Waiver Does Not Fill the Gap. https://acuity.news/regulation/dea-scheduling-7-oh-kratom-opioid-treatment-impact-2026/Acuity Newsen2026-08-06T05:29:59-06:00The DEA Is Moving to Ban 7-OH, the Gas-Station Opioid Most Users Thought Was a Supplement. Treatment Providers Should Expect the Fallout.